- Home
- HCTI vs GTBP Comparison
HCTI vs GTBP Comparison
Compare HCTI & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCTI | GTBP |
|---|---|---|
| Founded | 2020 | 1965 |
| Country | United States | United States |
| Employees | 58 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 12.4M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | HCTI | GTBP |
|---|---|---|
| Price | $0.66 | $6.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 228.8K |
| Earning Date | 04-16-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.75 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,891,000.00 | N/A |
| Revenue This Year | $79.33 | N/A |
| Revenue Next Year | $20.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 18.77 | N/A |
| 52 Week Low | $0.14 | $0.22 |
| 52 Week High | $9.97 | $11.98 |
Technical Indicators
Market Signals| Indicator | HCTI | GTBP |
|---|---|---|
| Relative Strength Index (RSI) | 37.66 | 62.81 |
| Support Level | $0.14 | $0.36 |
| Resistance Level | $1.01 | $11.98 |
| Average True Range (ATR) | 0.23 | 1.20 |
| MACD | 0.02 | -0.22 |
| Stochastic Oscillator | 1.24 | 20.83 |
Price Performance
Historical ComparisonAbout HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.